Exploring the syndrome differentiation of lung diseases in traditional Chinese medicine based on the Qihai theory using the Xuanjiang therapy
-
摘要: 气海主全身之气,气海调畅则肺气宣发肃降活动正常,若气海失司则气机宣降失调,而易生肺病,临证辨治当以宣降法为大法,以宣降气海气机,治疗肺病。基于此,本文基于气海理论对运用宣降法在中医肺病防治中的理论依据及临床运用进行探讨,气海理论是中医肺病辨治的指导理论,具有重要的理论意义与临床价值。从气海理论角度,对运用宣降法辨治常见肺病进行探讨,分别从病因、病机来详述分析,提出气海气机失调,宣降肺气辨治咳嗽;痰饮留伏气海,宣降利痰辨治哮病;邪热壅塞气海,宣降排脓辨治肺痈;气海肺络失养,宣降滋阴辨治肺痨;气海气机壅滞,宣降利气辨治肺胀;气海津液虚损,宣降布津辨治肺痿;参考相关文献并结合相关临床资料的治法、疗效进行总结。研究认为气海气机宣降失调是中医肺病的主要病理变化,在气海理论的指导下运用宣降法,合理选择方药进行辨治,可有效改善疾病症状,延缓病情发展,减少发作次数,提高患者生活质量。通过对气海紊乱在各肺系疾病中致病病机的详细论述,阐明以气海理论为指导,采用宣降气机、扶正祛邪的方法,在肺系疾病中的临床应用,可发挥中医药疗效优势,为肺病的中医诊疗和相关研究提供临床思路。Abstract: The Qihai is the primary Qi of the entire body. When the Qihai is in a state of smoothness, the Qi of lung is able to achieve normalization. Conversely, when the Qihai is in a state of disharmony, the Qi is also disrupted, which can result in the onset of lung diseases. The most effective treatment approach is to employ the method of declaring and descending the Qi movement of Qihai. This method is designed to address the underlying causes of lung diseases. This paper presents a discussion of the theoretical basis and clinical application of the Xuanjiang therapy in the prevention and treatment of lung diseases in traditional Chinese medicine (TCM), based on the theory of Qihai. The theory of Qihai provides a fundamental framework for the identification and treatment of lung diseases in TCM, offering significant theoretical insights and clinical value. From the perspective of Qihai theory, this paper discusses the use of the Xuanjiang therapy in the treatment of common lung diseases. It analyzes the causes and mechanisms of these diseases in detail and proposes that Qi movement of Qihai dysfunction, Xuanjiang lung Qi treatment for cough; phlegm stays in Qihai, Xuanjiang phlegm treatment for croup; Evil heat congestion of the Qihai, Xuanjiang pus treatment for lung carbuncle; Qihai lung ligament loss of nourishment, Xuanjiang nourishing yin treatment for consumption; Qi movement of Qihai congestion, Xuanjiang regulating Qi treatment for pulmonary distension; Qihai fluid loss, Xuanjiang dispering fluid treatment for lung impotence; and Xuanjiang Bujin treatment for lung impotence. The treatment of lung impotence was identified with reference to relevant literature and clinical data, and a summary of the treatment method and efficacy was provided. It is hypothesized that the primary pathological alteration in lung diseases within the context of Chinese medicine is the dysregulation of Qi propagation and descending. The utilization of the propagation and descending method, in conjunction with the guidance of the theory of Qihai and the rational selection of prescription drugs, has the potential to effectively improve the symptoms of the disease, delay its progression, reduce the frequency of episodes and enhance the quality of life for patients. By examining the pathogenesis of Qihai disorders in various lung diseases in detail, it becomes evident that the clinical application of the Qihai theory as a guide to promote and reduce Qi, support the positive and eliminate the evil in lung diseases can fully utilize the efficacy of TCM, and provide a clinical idea for the TCM diagnosis and treatment of lung diseases and the related research.
-
Key words:
- Lung disease /
- Respiratory disease /
- Qihai /
- Xuanjiang therapy /
- Traditional Chinese medicine therapy
-
[1] 肖泓, 韦衮政. 中医肺病学[M]. 北京: 科学出版社, 2018: 1.XIAO H, WEI G Z. Chinese medicine lung disease[M]. Beijing: Science Press, 2018: 1 [2] 岳广晴, 申鹏飞, 姜泽飞, 等. 基于"气海"理论探讨国医大师石学敏针刺人迎穴降压的临证特点[J]. 针灸临床杂志, 2022, 38(3): 77-80.YUE G Q, SHEN P F, JIANG Z F, et al. Blood pressure-lowering effect of needling ST9 by professor SHI Xuemin based on Qihai Theory[J]. Acupuncture and Moxibustion Clinical Journal, 2022, 38(3): 77-80. [3] 杨燕, 胡镜清, 彭锦, 等. 宗气理论概述及现代研究进展[J]. 世界科学技术-中医药现代化, 2014, 16(11): 2435-2439. doi: 10.11842/wst.2014.11.027YANG Y, HU J Q, PENG J, et al. Overview of Zongqi theory and progress of modern research[J]. World Science and Technology-Modernization of Chinese Medicine, 2014, 16(11): 2435-2439. doi: 10.11842/wst.2014.11.027 [4] 邵牛, 包素珍. 宗气与生命节律的调控[J]. 中国中医基础医学杂志, 2021, 27(10): 1543-1544, 1548.SHAO N, BAO S Z. Zongqi and the regulation of life rhythm[J]. Chinese Journal of Basic Chinese Medicine, 2021, 27(10): 1543-1544, 1548. [5] 吴蕾, 郑俐慈, 陈远彬, 等. 基于宗气、元气理论探讨慢性阻塞性肺疾病的病机与辨治[J]. 中医杂志, 2023, 64(14): 1440-1443.WU L, ZHENG L C, CHEN Y B, et al. Discussion on the pathogenesis and treatment of chronic obstructive pulmonary disease based on the theory of Zongqi and Yuanqi[J]. Journal of Traditional Chinese Medicine, 2023, 64(14): 1440-1443. [6] 咳嗽的诊断依据、证候分类、疗效评定[J]. 辽宁中医杂志, 2021, 48(5): 213.Diagnostic basis, symptomatic classification, and efficacy evaluation of cough[J]. Liaoning Journal of Chinese Medicine, 2021, 48(5): 213. [7] 中华医学会呼吸病学分会哮喘学组. 咳嗽的诊断与治疗指南(2021)[J]. 中华结核和呼吸杂志, 2022, 45(1): 13-46.Asthma Group of the Respiratory Diseases Branch of the Chinese Medical Association. Guidelines for the diagnosis and treatment of cough (2021)[J]. Chinese Journal of Tuberculosis and Respiratory, 2022, 45(1): 13-46. [8] 宋文茜, 唐艳艳, 李虹. 李虹治疗慢性咳嗽临证医案[J]. 浙江中医杂志, 2023, 58(10): 774-775.SONG W Q, TANG Y Y, LI H. A clinical case of chronic cough treated by Li Hong[J]. Zhejiang Journal of Traditional Chinese Medicine, 2023, 58(10): 774-775. [9] 安继仁, 杨新栎, 宋纪显, 等. 半夏厚朴汤治疗呼吸系统疾病研究进展[J]. 中国实验方剂学杂志, 2023, 29(5): 236-245.AN J R, YANG X L, SONG J X, et al. Progress in the treatment of respiratory diseases by Banxia Houpu Tang[J]. Chinese Journal of Experimental Formulas, 2023, 29(5): 236-245. [10] 张洪春, 王成祥, 崔红生, 等. 宣肺止嗽合剂治疗咳嗽临床应用专家共识[J]. 中华中医药学刊, 2022, 40(8): 252-258.ZHANG H C, WANG C X, CUI H S, et al. Expert consensus on clinical application of Xuanfei Zhisou Mixture in treatment of cough (Wind Evil Invading Lung Syndrome)[J]. Chinese Journal of Traditional Chinese Medicine, 2022, 40(8): 252-258. [11] 钟云青. 宣肺止嗽合剂辅助治疗咳嗽变异性哮喘的风邪犯肺证患者[J]. 中成药, 2017, 39(5): 912-915.ZHONG Y Q. Supplementary effects of Xuanfei Zhisou Mixture on cough variant asthma in patients with syndrome of wind pathogen invading lung[J]. Chinese Patent Medicine, 2017, 39(5): 912-915. [12] 张洪春, 杨道文, 崔红生, 等. 宣肺止嗽合剂对感染后咳嗽(风邪犯肺证)中医证候和生活质量的影响观察: 一项随机、安慰剂对照、双盲、多中心临床研究[J]. 中华中医药学刊, 2024, 42(7): 1-5.ZHANG H C, YANG D W, CUI H S, et al. Randomized double-blind multicenter study on Xuanfei Zhisou Mixture in treatment of acute bronchitis (wind evil invading lung type)[J]. Chinese Archives of Traditional Chinese Medicine, 2024, 42(7): 1-5. [13] 方芳, 周怡, 叶龙, 等. 三拗汤合三子养亲汤加减治疗对小儿过敏性咳嗽中医证候评分、免疫功能及炎性因子水平的影响[J]. 中华中医药学刊, 2024, 42(2): 38-41.FANG F, ZHOU Y, YE L, et al. Effect of Sanao Decoction combined with Sanzi Yangqin Decoction on TCM syndrome score, lmmune function and inflammatory factor levels in children with allergic cough[J]. Chinese Archives of Traditional Chinese Medicine, 2024, 42(2): 38-41. [14] 焦蕊, 庞立健, 吕晓东. 基于网络药理学探讨三拗汤治疗咳嗽变异型哮喘的作用机制[J]. 中华全科医学, 2021, 19(7): 1218-1223. doi: 10.16766/j.cnki.issn.1674-4152.002025JIAO R, PANG L J, LYU X D. Exploring the mechanism of action of San'ao Tang in the treatment of cough variant asthma based on network pharmacology[J]. Chinese Family Medicine, 2021, 19(7): 1218-1223. doi: 10.16766/j.cnki.issn.1674-4152.002025 [15] 李得民, 张洪春. 中医内科病证诊断疗效标准·哮病(修订版)[J]. 中医杂志, 2020, 61(9): 827-828.LI D M, ZHANG H C. Diagnostic and therapeutic efficacy criteria of internal medicine in Chinese medicine-croup (revised edition)[J]. Journal of Traditional Chinese Medicine, 2020, 61(9): 827-828. [16] 马爱贤, 宋嘉懿, 王强, 等. 孙增涛应用射干麻黄汤治疗支气管哮喘经验[J]. 江西中医药, 2023, 54(4): 24-27.MA A X, SONG J Y, WANG Q, et al. SUN Zeng-tao's experience in treating bronchial asthma with Shegan Mahuang Decotion[J]. Jiangxi Traditional Chinese Medicine, 2023, 54(4): 24-27. [17] 蒋浩, 卢婧, 黄霞, 等. 疏风益肺定喘汤治疗支气管哮喘(风哮证)疗效及对患者MMP-9、IL-17、TIMP-1水平的影响[J]. 四川中医, 2021, 39(6): 113-116.JIANG H, LU J, HUANG X, et al. Efficacy of Shufeng Yifei Dingchuan Soup in treating bronchial asthma (wind croup syndrome) and its effect on MMP-9, IL-17 and TIMP-1 levels in patients[J]. Sichuan Traditional Chinese Medicine, 2021, 39(6): 113-116. [18] 杨福双, 王烈, 孙丽平. 国医大师王烈运用十君子汤治疗儿童支气管哮喘慢性持续期经验[J]. 中华中医药杂志, 2023, 38(9): 4175-4178.YANG F S, WANG L, SUN L P. Experiences of national medical master Wang Lie in treating chronic persistent stage of bronchial asthma in children by using Shijunzi Soup[J]. Chinese Journal of Traditional Chinese Medicine, 2023, 38(9): 4175-4178. [19] 国家中医药管理局. 肺痈的诊断依据、证侯分类、疗效评定: 中华人民共和国中医药行业标准《中医内科病证诊断疗效标准》(ZY/T001.1-94)[S]//南京: 南京大学出版社, 1994: 4.National Administration of Traditional Chinese Medicine. Diagnostic basis, evidence classification, and efficacy assessment of pulmonary carbuncle: People's Republic of China Chinese medicine industry standard "Diagnostic and efficacy standard of Chinese medicine internal medicine" (ZY/T001.1-94)[S]. Nanjing: Nanjing University Press, 1994: 4. [20] 梁佳佳, 许先荣. 加味千金苇茎汤结合支气管肺泡灌洗术治疗痰热壅肺型急性肺脓肿37例[J]. 浙江中医杂志, 2018, 53(9): 687.LIANG J J, XU X R. Treating 37 cases of acute lung abscess caused by phlegm-heat obstructing lung with added Qianjin Weijian Decoction combined with bronchoalveolar lavage[J]. Zhejiang Journal of Traditional Chinese Medicine, 2018, 53(9): 687. [21] 关建新, 伊明洋, 李海霞, 等. 千金苇茎汤治疗呼吸系统疾病的相关研究进展[J]. 中华中医药学刊, 2023, 41(9): 120-125.GUAN J X, YI M Y, LI H X, et al. Research progress of Qianjin Weijing Decoction in treatment of respiratory diseases[J]. Chinese Journal of Traditional Chinese Medicine, 2023, 41(9): 120-125. [22] 王文静. 葶苈大枣泻肺汤对肺脓肿患者肺功能及炎症反应的影响[J]. 光明中医, 2022, 37(19): 3533-3535.WANG W J. Effect of Tingli Dazao Xiefei Decoction on pulmonary function and inflammation in patients with lung abscess[J]. Guangming Traditional Chinese Medicine, 2022, 37(19): 3533-3535. [23] 潘静洁, 刘堂营, 黄晋, 等. 应用加味百合固金汤治疗肺结核患者的临床效果观察[J]. 实用医学杂志, 2022, 38(13): 1614-1617.PAN J J, LIU T Y, HUANG J, et al. Observations on the clinical effect of applying the flavored Baihe Gujin Tang in treating patients with pulmonary tuberculosis[J]. Journal of Practical Medicine, 2022, 38(13): 1614-1617. [24] 张敏, 许成辰, 徐婷贞, 等. 基于Nrf2/Keap1/p62信号通路探讨百合固金汤对LPS诱导的小鼠急性肺损伤的保护作用[J]. 中国实验方剂学杂志, 2019, 25(15): 77-82.ZHANG M, XU C C, XU T Z, et al. Effect of Baihe Gujin Tang on LPS-induced acute lung injury in mice based on Nrf2/Keap1/p62 signaling pathway[J]. Chinese Journal of Experimental Formulas, 2019, 25(15): 77-82. [25] 左军, 尹柏坤, 胡晓阳. 桔梗化学成分及现代药理研究进展[J]. 辽宁中医药大学学报, 2019, 21(1): 113-116.ZUO J, YI B K, HU X Y. Progress of chemical composition and modern pharmacological research on Platycodon grandiflorum[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2019, 21(1): 113-116. [26] 彭婉, 马骁, 王建, 等. 麦冬化学成分及药理作用研究进展[J]. 中草药, 2018, 49(2): 477-488.PENG W, MA X, WANG J, et al. Progress of research on chemical composition and pharmacological effects of Maitong[J]. Chinese Herbal Medicine, 2018, 49(2): 477-488. [27] 袁泽玥, 张典, 崔迎春. 百合多糖的药理作用研究进展[J]. 科学技术创新, 2020(15): 25-26.YUAN Z Y, ZHANG D, CUI Y C. Progress in the study of pharmacological effects of lily polysaccharides[J]. Science and Technology Innovation, 2020(15): 25-26. [28] 杨鹏, 崔玉秀, 胡菊, 等. 养阴润肺汤对肺结核患者痰菌涂片转阴情况和免疫功能的影响[J]. 吉林中医药, 2021, 41(8): 1046-1049.YANG P, CUI Y X, HU J, et al. Effect of Yangyin Runfei Decoction on the sputum smears turning negative and the immune function in patients with pulmonary tuberculosis[J]. Jilin Chinese Medicine, 2021, 41(8): 1046-1049. [29] 黄杰, 唐艳芬, 苏成程, 等. 小柴胡汤合苓甘五味姜辛汤加减治疗慢性阻塞性肺疾病急性加重期外寒内饮证的临床疗效及对炎症因子和免疫功能的影响[J]. 河北中医, 2023, 45(11): 1806-1810.HUANG J, TANG Y F, SU C C, et al. Clinical efficacy of modified Xiaochaihu Decoction and Linggan Wuwei Jiangxin Decoction on acute exacerbation of chronic obstructive pulmonary disease of external cold and internal drinking and its influence on inflammatory factor and immune function[J]. Hebei Traditional Chinese Medicine, 2023, 45(11): 1806-1810. [30] 陈炜, 张念志, 朱福生. 四子温肺汤治疗慢性阻塞性肺疾病急性加重期痰湿蕴肺证患者临床观察[J]. 西部中医药, 2023, 36(10): 125-128.CHEN W, ZHANG N Z, ZHU F S. Clinical observation on the treatment of patients with phlegm-dampness-embedded lung syndrome during acute exacerbation of chronic obstructive pulmonary disease with Sizi Wenlong Tang[J]. Western Traditional Chinese Medicine, 2023, 36(10): 125-128. [31] 林婷婷, 王慧, 张真, 等. 复方葶苈子汤治疗慢性肺源性心脏病的作用机制研究[J]. 中医药临床杂志, 2023, 35(6): 1117-1123.LIN T T, WANG H, ZHANG Z, et al. Study on the mechanism of Compound Tinglizi Decoction in treating chronic cor pulmonale[J]. Journal of Traditional Chinese Medicine, 2023, 35(6): 1117-1123. [32] 王国梁, 杨华, 孙丽凤, 等. 达络肺仙饮治疗特发性肺纤维化疗效及机制研究[J]. 山东中医杂志, 2023, 42(6): 564-569, 582.WANG G L, YANG H, SUN L F, et al. Therapeutic effect and mechanism of Daluo Feixian Decoction on idiopathic pulmonary fibrosis[J]. Shandong Journal of Traditional Chinese Medicine, 2023, 42(6): 564-569, 582. [33] 杨丹榕, 任涛. 间质性肺疾病概述[J]. 临床内科杂志, 2022, 39(10): 649-652.YANG D R, REN T. Overview of interstitial lung diseases[J]. Journal of Clinical Internal Medicine, 2022, 39(10): 649-652. [34] 黄振峰, 于会勇, 王成祥. 清燥救肺汤联合吡非尼酮治疗特发性肺纤维化疗效及对患者支气管肺泡灌洗液胰岛素样生长因子的影响[J]. 陕西中医, 2023, 44(8): 1037-1041.HUANG Z F, YU H Y, WANG C X. Effect of Qingzao Jiufei decoction combined with pirfenidone on idiopathic pulmonary fibrosis and insulin-like growth factor in patients with bronchoalveolar lavage solution[J]. Shaanxi Traditional Chinese Medicine, 2023, 44(8): 1037-1041.
点击查看大图
计量
- 文章访问数: 21
- HTML全文浏览量: 13
- PDF下载量: 2
- 被引次数: 0